Kaneka Expands into European Market with i-ED COIL™ Launch

Published: 10 Nov 2025

Author: Precedence Research

Share :

Kaneka Corporation has launched i-ED COILtm in Europe after receiving EC certification under the EU Medical Device Regulation (MDR). The license, issued in July, is a significant move towards Kaneka's strategic growth in the European medical device market. Kaneka Medical Europe N.V. will be the distributor of the i-ED COILtm, which will strengthen the company's commitment to offering innovative, life-saving neurovascular solutions to patients across the globe.

The i-ED COILtm features a special structural design and a specific wire thickness, providing high flexibility and packing density. This allows neurosurgeons to treat aneurysms of different shapes and complexity with more accuracy. This coil, first introduced in Japan successfully in 2019, has been universally praised by physicians. Because it provides a higher rate of tighter, safer aneurysm occlusion, which reduces the threat of rupture to a large extent. This European launch is a defining moment in Kaneka's long-term perspective to globalize its medical device portfolio and become a market leader in next-generation interventional treatment technologies.

In addition to the i-ED COILtm, the Health Care Solutions Unit at Kaneka is still expanding into a wide range of medical fields, including cardiac, peripheral vascular, and gastrointestinal therapies. The company is incorporating new technology in biomaterials and precision-engineering processes to develop new medical equipment that facilitates minimally invasive surgery. Kaneka also targets 300 billion yen in sales for the healthcare business unit by 2030, spearheaded by global expansion, investments in R&D, and collaborations with hospitals and clinical research centers in Asia, Europe, and North America.

The European introduction of the i-ED COILtm is indicative of the direction Kaneka has taken, implementing Japanese-level engineering precision and global medical partnerships to bring state-of-the-art care closer to people. Kaneka summarizes its vision of applying science and innovation to improve the quality of life all over the world. Furthermore, with the collaboration of European neurosurgeons, hospitals, and distributors, Kaneka seeks to acquire real-world data that will inform future advances in treating neurovascular conditions.